Stockscreener 앱 받기
0.3281
3.02%
-0.0102
시간 외 거래:
.32
-0.0081
-2.47%
Profusa Inc 주식(PFSA)의 최신 뉴스
Profusa files prospectus relates to resale of up to 42.6 mln shares - MarketScreener
Profusa injects additional USD 1M into digital treasury assets - Medical Buyer
Profusa Invests $1 Million in Digital Treasury Assets - TipRanks
Profusa makes second $1 million bitcoin investment to hedge risks By Investing.com - Investing.com Nigeria
Profusa invests additional $1 million in digital treasury assets - MSN
Profusa, Inc. announced that it has received $1 million in funding - MarketScreener
Profusa invests additional $1 million in bitcoin treasury assets By Investing.com - Investing.com
Profusa, Inc. Announces $1 Million Investment in Digital Treasury Assets to Support Biochemical Monitoring Technology - Quiver Quantitative
Second $1M Investment: Profusa Expands Bitcoin Digital Treasury Strategy; Ascent Funds $2M Tranche - Stock Titan
French vascular surgeon adopts Profusa’s oxygen monitoring tech By Investing.com - Investing.com Nigeria
French vascular surgeon adopts Profusa’s oxygen monitoring tech - Investing.com India
Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base - The Manila Times
8% of French CLTI Cases: Profusa's Lumee Technology Gains Major Adoption from Leading Surgeon Network - Stock Titan
Profusa’s Risky Vision for High-Tech Medical Sensors - Finimize
Profusa Restructures Securities Agreement for Flexibility - MSN
Profusa Faces Nasdaq Listing Compliance Challenges - MSN
Profusa receives Nasdaq notices for minimum value and bid price compliance - Investing.com
Profusa Approves $100 Million Equity Line of Credit - MSN
This Penny Stock Is Surging on an Nvidia Boost. Should You Buy Shares Now or Stay Far Away? - Barchart.com
Profusa (PFSA) Stock: Soars 76% on NVIDIA-Powered AI Breakthrough in Biochemistry Monitoring - parameter.io
Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen Platform - Yahoo Finance
Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring - GlobeNewswire
Profusa, Inc. Adopts NVIDIA -Powered Technology to Build Ai-Driven Insight Portal for Continuous Biomarker Monitoring - MarketScreener
Profusa shareholders approve $100 million equity line of credit with Ascent Partners By Investing.com - Investing.com South Africa
Profusa shareholders approve $100 million equity line of credit with Ascent Partners - Investing.com Australia
Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base - GlobeNewswire
300+ CLTI Patients Annually: Profusa's Oxygen Monitoring Tech Enters Major Belgian Hospital - Stock Titan
Profusa's Strategic Position in Digital Health Innovation - AInvest
Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Digital Health Pioneer Profusa to Showcase Continuous Biochemistry Monitoring Tech at Major Conference - Stock Titan
Profusa announces commercial and clinical collaboration with head of angiography, Medical University of Graz, Austria - MarketScreener
Profusa Announces Commercial and Clinical Collaboration - GlobeNewswire
Leading Vascular Center Adopts Profusa's Real-Time Oxygen Monitoring Tech for 1,500 Annual Procedures - Stock Titan
Profusa amends purchase agreement and note terms for convertible debt tranches - Investing.com Australia
Profusa Restructures Securities Agreement for Enhanced Flexibility - AInvest
1.83%
자본화:
|
볼륨(24시간):